Literature DB >> 90156

Immunological characterization of mouse mammary tumor virus p10 and its presence in mammary tumors and sera of tumor-bearing mice.

L O Arthur, D L Fine.   

Abstract

Mouse mammary tumor virus (MMTV) p10 and gp52 were purified and used as radiolabeled antigens in sensitive radioimmunoassays. These radioimmunoassays were specific for MMTV proteins since detergent-disrupted MMTV from C3H/HeN, RIII, and GR/N mice gave complete competition, whereas C3H/HeNf liver extracts and other lysed retroviruses did not. Both gp52 and p10 are coded by the viral genome, since MMTV grown in a heterologous cell line (feline kidney cells) competed in these assays. Sera from mammary tumor-bearing mice and mammary tumors from C3H/HeN and C3H/HeNf mice competed in both the gp52 and the p10 assays. Although these radioimmunoassays detected predominantly group-specific antigenic determinants in C3H/HeN and C3H/HeNf tumor extracts, type specificity was also found with gp52. Absorption of the anti-MMTV serum with C3H/HeNf tumor extracts removed all antibodies directed against p10 and decreased the anti-gp52 titer approximately 30-fold. When this absorbed antiserum was used at limiting dilution in the gp52 radioimmunoassay, C3H/HeN tumor extracts gave complete competition, whereas no competition was found with C3H/HeNf tumor extracts.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 90156      PMCID: PMC353309          DOI: 10.1128/JVI.30.1.148-156.1979

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography.

Authors:  R A Laskey; A D Mills
Journal:  Eur J Biochem       Date:  1975-08-15

3.  Polypeptides of the mouse mammary tumor virus. II. Identification of two major glycoproteins with the viral structure.

Authors:  N H Sarkar; N E Taraschi; A A Pomenti; A S Dion
Journal:  Virology       Date:  1976-02       Impact factor: 3.616

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Radioimmunoassay for glycoprotein gp47 of murine mammary tumor virus in organs and serum of mice and search for related antigens in human sera.

Authors:  P F Zangerie; C M Calberg-Bacq; C Colin; P Franchimont; C François; L Gosselin; S Kozma; P M Osterrieth
Journal:  Cancer Res       Date:  1977-12       Impact factor: 12.701

6.  Identification of a precursor protein to the major glycoproteins of mouse mammary tumor virus.

Authors:  C Dickson; J P Puma; S Nandi
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

7.  Procedures for radioimmunoassay of the mouse mammary tumor virus.

Authors:  J B Sheffield; T Daly; A S Dion; N Taraschi
Journal:  Cancer Res       Date:  1977-05       Impact factor: 12.701

8.  Immunologic studies of the low molecular weight DNA binding protein of murine oncornaviruses.

Authors:  C W Long; T R Berzinski; R V Gilden
Journal:  Int J Cancer       Date:  1977-06-15       Impact factor: 7.396

9.  Plasma levels of a viral protein as a diagnostic signal for the presence of tumor : the murine mammary tumor model.

Authors:  E Ritzi; D S Martin; R L Stolfi; S Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

10.  Plasma levels of a viral protein as a diagnostic signal for the presence of mammary tumor: the effect of tumor removal.

Authors:  E Ritzi; D S Martin; R L Stolfi; S Spiegelman
Journal:  J Exp Med       Date:  1977-04-01       Impact factor: 14.307

View more
  6 in total

1.  Establishment of a C3Hf mammary tumor cell line expressing endogenous mouse mammary tumor virus: antigenic and genetic relationships of this virus with highly oncogenic mouse mammary tumor viruses.

Authors:  L O Arthur; G G Lovinger; G Schochetman
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

2.  Mice with spontaneous mammary tumors develop type-specific neutralizing and cytotoxic antibodies against the mouse mammary tumor virus envelope protein gp52.

Authors:  G Schochetman; L O Arthur; C W Long; R J Massey
Journal:  J Virol       Date:  1979-10       Impact factor: 5.103

3.  Immunological characterization of a low oncogenic mouse mammary tumor virus BALB/cNIV mice.

Authors:  J P Vacquier; R D Cardiff; P B Blair
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

4.  Processing and amino acid sequence analysis of the mouse mammary tumor virus env gene product.

Authors:  L O Arthur; T D Copeland; S Oroszlan; G Schochetman
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

5.  Monoclonal antibodies identify individual determinants on mouse mammary tumor virus glycoprotein gp52 with group, class, or type specificity.

Authors:  R J Massey; L O Arthur; R C Nowinski; G Schochetman
Journal:  J Virol       Date:  1980-06       Impact factor: 5.103

6.  C3H/HeN mammary tumor-bearing mice develop type-specific neutralizing antibodies and group-specific precipitating antibodies for the mouse mammary tumor virus.

Authors:  R Massey; L O Arthur; C W Long; G Schochetman
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.